NCT07402850Completed
Oscillating Positive Expiratory Pressure Therapy Versus Autogenic Drainage in Patients With COPD
Oscillating Positive Expiratory Pressure Therapy Versus Autogenic Drainage in Patients With Chronic Obstructive Pulmonary Disease: Effects on Pulmonary Function, Sputum Clearance, Dyspnea, and Quality of Life
Source: ClinicalTrials.gov · Last updated 11 Feb 2026
Brief summary (registry, in English)
Chronic Obstructive Pulmonary Disease (COPD) is a long-term lung condition that causes breathing difficulty, cough, and sputum production. Airway clearance techniques are commonly used to help reduce symptoms and improve breathing in patients with COPD. This study compared two airway clearance methods-oscillating positive expiratory pressure (OPEP) therapy and autogenic drainage-to determine which method is more effective in improving lung function, sputum clearance, shortness of breath, and quality of life in patients with COPD. Participants were divided into two groups and received either OPEP therapy or autogenic drainage for four weeks. Outcomes were measured at the beginning of the study and again after completion of the intervention. The findings of this study aim to support evidence-based physiotherapy management for patients with COPD.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 58 (actual)
- First submitted
- 26 Jan 2026
- Start date
- 5 May 2025
- Primary completion date
- 8 Aug 2025
- Lead sponsor
- Adnan Hashim
- Diseases
- COPD
- NCT number
- NCT07402850
What you commit to
- Study type: Interventional
- Participants enrolled: 58
- From 5 May 2025 to the primary completion date, 8 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent thoracic or abdominal surgery
Other illness
- Severe cardiovascular, neurological, or musculoskeletal disorders
- Presence of other significant respiratory diseases
Other
- Acute exacerbation of COPD
- Unwillingness to participate or inability to comply with the study protocol
Who the study is looking for
- Age between 35 and 50 years
- Both genders
- Participants must have a confirmed diagnosis of Chronic Obstructive Pulmonary Disease (COPD) based on the GOLD 2023 guidelines
- Clinically stable
- History of Sputum Culture
Age in the registry: 35 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.